Neonatal Kidney Size and Function in Preterm Infants: What Is a True Estimate of Glomerular Filtration Rate? - 16/04/14
, Wacharee Seeherunvong, MD 1, Marta G. Galarza, MD 2, Chryso Katsoufis, MD 1, Denise Francoeur, RN 1, Marissa DeFreitas, MD 1, Alcia Edwards-Richards, MD 1, Vimal Master Sankar Raj, MD 1, Jayanthi Chandar, MD 1, Shahnaz Duara, MD 2, Salih Yasin, MD 3, Gaston Zilleruelo, MD 1Abstract |
Objectives |
To distinguish between cystatin C (CysC) and creatinine (Cr) as markers of estimated glomerular filtration rate (eGFR) in preterm infants and to correlate eGFR with total kidney volume (TKV) as a surrogate of nephron mass.
Study design |
Sixty preterm (<37 weeks' gestational age [GA]) and 40 term infants were enrolled at birth. Serum Cr and CysC levels were assessed during the first week of life. Renal ultrasounds were performed to assess kidney dimensions with calculation of the TKV as a surrogate of nephron mass. Six equations derived from reference inulin, iohexol, and iothalamate clearance studies were used to calculate eGFR. Multiple regression analysis was applied to assess the relative impact of neonatal measures on eGFR, including TKV, GA, and mean arterial pressure (MAP).
Results |
Renal lengths correlated with GA and were within the reference values for intrauterine measurements. Estimation equations for glomerular filtration rate (GFR) based on Cr, CysC, and combined CysC + Cr demonstrated that Cr-based equations consistently underestimated GFR, whereas CysC and combined equations were more consistent with referenced inulin clearance studies. Term infants demonstrated significantly better eGFR than preterm infants. TKV, GA, and MAP correlated positively with eGFR, although only MAP and GA remained significant when adjusted for other covariates.
Conclusions |
Primary determinants of eGFR in preterm infants are GA and MAP. The CysC level is a superior biomarker to serum Cr in the assessment of GFR in premature infants.
Le texte complet de cet article est disponible en PDF.Keyword : AKI, Cr, CysC, eGFR, GA, GFR, iGFR, MAP, SES, TKV
Plan
| Supported by a grant from the Gerber Foundation and Children's Medical Services, Florida Department of Health. The authors declare no conflicts of interest. |
Vol 164 - N° 5
P. 1026 - mai 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
